Investing.com - Amicus reported on Monday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Amicus announced earnings per share of $-0.120 on revenue of $81.69M. Analysts polled by Investing.com EPS of $-0.189 on revenue of $84.33M.
Amicus 's are down 28% and is trading at $9.875 , still down 23.80% from its 52 week high of $12.96 set on Thursday, August 25, 2022.
Amicus shares lost 2.32% to trade at $9.875 in intra-day trade the report.
Amicus follows other major Healthcare sector earnings this month
Amicus's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar